@article{5431579b7f884675a4fa35a14e98d7a6,
title = "Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn{\textquoteright}s Disease: An Open-Label Pilot Study",
author = "James, \{Dustin G.\} and Jiajing Chen and Caroline Vemulapalli and Stone, \{Christian D.\} and Stone, \{Christian D.\}",
note = "Background and aims: Efalizumab is a monoclonal antibody targeting CD11a, an adhesion molecule involved in the activation and trafficking of T-lymphocytes. This agent has proven efficacy in the treatment of psoriasis. We performed an open-label study to evaluate the efficacy and safety of efalizumab in Crohn's disease (CD).",
year = "2011",
month = jun,
day = "1",
doi = "10.1007/S10620-010-1525-6",
language = "American English",
volume = "56",
journal = "Digestive Diseases and Sciences",
issn = "1573-2568",
publisher = "Springer",
number = "6",
}